
Apellis Pharmaceuticals (APLS) Financial Statements
Price: $18.2
Market Cap: $2.28B
Avg Volume: 1.96M
Market Cap: $2.28B
Avg Volume: 1.96M
Country: US
Industry: Biotechnology
Sector: Healthcare
Industry: Biotechnology
Sector: Healthcare
Overview of Financial Statements
Financial statements are records that provide an overview of a company's financial performance and position. There are three main types of financial statements:
- Income Statement: Shows the company's revenue, expenses, and profit over a specific period.
- Balance Sheet: Provides a snapshot of the company's assets, liabilities, and equity at a specific point in time.
- Cash Flow Statement: Details the cash inflows and outflows from operating, investing, and financing activities over a period.
This page presents both annual and quarterly data for these financial statements. The charts below provide a visual representation of the key metrics from each statement, helping you to quickly understand the financial health of Apellis Pharmaceuticals.
Income Statement
Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 | December 31, 2018 | December 31, 2017 | December 31, 2016 | December 31, 2015 |
---|---|---|---|---|---|---|---|---|---|---|
Revenue | $709.95M | $396.59M | $75.42M | $66.56M | $250.65M | $- | $- | $- | $- | $- |
Cost of Revenue | $117.72M | $58.51M | $5.64M | $5.20M | $25.05M | $288.02M | $127.92M | $50.77M | $- | $- |
Gross Profit | $592.23M | $338.08M | $69.79M | $61.36M | $225.60M | $-288.02M | $-127.92M | $-50.77M | $- | $- |
Gross Profit Ratio | 83.42% | 85.25% | 92.53% | 92.19% | 90.01% | - | - | - | 0.00% | 0.00% |
Research and Development Expenses | $327.57M | $354.39M | $387.24M | $420.87M | $299.92M | $220.97M | $105.29M | $40.30M | $22.98M | $13.73M |
General and Administrative Expenses | $- | $500.81M | $277.16M | $176.77M | $139.40M | $67.05M | $22.64M | $10.46M | $4.30M | $6.36M |
Selling and Marketing Expenses | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Selling General and Administrative Expenses | $501.05M | $500.81M | $277.16M | $176.77M | $139.40M | $67.05M | $22.64M | $10.46M | $4.30M | $6.36M |
Other Expenses | $- | $- | $-288.00K | $1.36M | $-501.00K | $-175.31K | $-110.76K | $11.54K | $157.71K | $6.28K |
Operating Expenses | $828.62M | $855.20M | $664.40M | $597.64M | $439.32M | $288.02M | $127.92M | $50.77M | $27.28M | $20.09M |
Cost and Expenses | $946.35M | $913.71M | $670.03M | $602.84M | $464.37M | $288.02M | $127.92M | $50.77M | $27.28M | $20.09M |
Interest Income | $12.77M | $20.93M | $8.91M | $418.00K | $4.16M | $5.11M | $2.96M | $- | $- | $- |
Interest Expense | $40.39M | $29.58M | $32.63M | $13.24M | $29.94M | $5.28M | $2.51M | $96.92K | $- | $- |
Depreciation and Amortization | $1.80M | $1.70M | $1.49M | $1.49M | $859.00K | $595.45K | $127.92M | $11.94K | $27.28M | $52.97M |
EBITDA | $-236.39M | $-495.21M | $-617.39M | $-731.27M | $-312.23M | $-298.83M | $- | $-50.90M | $157.71K | $6.40M |
EBITDA Ratio | -33.30% | -124.87% | -818.58% | -1098.61% | -124.57% | - | 0.00% | - | - | - |
Operating Income | $-236.39M | $-517.12M | $-594.61M | $-536.28M | $-213.73M | $-288.02M | $-127.92M | $-50.77M | $-27.28M | $-46.57M |
Operating Income Ratio | -33.30% | -130.39% | -788.38% | -805.67% | -85.27% | - | - | - | - | - |
Total Other Income Expenses Net | $39.68M | $-9.38M | $-56.89M | $-209.72M | $-129.30M | $-16.69M | $422.81K | $-239.06K | $157.71K | $57.14K |
Income Before Tax | $-196.72M | $-526.50M | $-651.50M | $-746.00M | $-343.03M | $-304.71M | $-127.50M | $-51.01M | $-27.12M | $-46.52M |
Income Before Tax Ratio | -27.71% | -132.76% | -863.81% | -1120.75% | -136.86% | - | - | - | - | - |
Income Tax Expense | $1.16M | $2.13M | $669.00K | $352.00K | $1.84M | $5.11M | $-533.32K | $250.61K | $-27.28M | $-26.54M |
Net Income | $-197.88M | $-528.63M | $-652.17M | $-746.35M | $-344.87M | $-309.82M | $-127.50M | $-51.01M | $-27.12M | $-46.52M |
Net Income Ratio | -27.87% | -133.29% | -864.70% | -1121.27% | -137.59% | - | - | - | - | - |
EPS | $-1.60 | $-4.45 | $-6.15 | $-8.84 | $-4.59 | $-4.98 | $-2.34 | $-3.68 | $-1.50 | $-2.57 |
EPS Diluted | $-1.60 | $-4.45 | $-6.15 | $-8.84 | $-4.59 | $-4.98 | $-2.34 | $-3.68 | $-1.50 | $-2.57 |
Weighted Average Shares Outstanding | 123.90M | 118.68M | 106.11M | 84.42M | 75.16M | 62.23M | 54.40M | 13.87M | 18.09M | 18.09M |
Weighted Average Shares Outstanding Diluted | 123.90M | 118.68M | 106.11M | 84.42M | 75.16M | 62.23M | 54.40M | 13.87M | 18.09M | 18.09M |
SEC Filing | Source | Source | Source | Source | Source | Source | Source | Source | Source | Source |
Balance Sheet
Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 | December 31, 2018 | December 31, 2017 | December 31, 2016 | December 31, 2015 |
---|---|---|---|---|---|---|---|---|---|---|
Cash and Cash Equivalents | $411.29M | $351.19M | $551.80M | $640.19M | $565.78M | $351.99M | $176.27M | $175.64M | $24.86M | $36.00M |
Short Term Investments | $- | $1.11M | $6.50M | $60.36M | $311.87M | $- | $- | $- | $- | $- |
Cash and Short Term Investments | $411.29M | $352.30M | $551.80M | $700.55M | $877.65M | $351.99M | $176.27M | $175.64M | $24.86M | $36.00M |
Net Receivables | $264.93M | $206.44M | $7.73M | $10.10M | $25.00M | $- | $- | $- | $- | $- |
Inventory | $81.40M | $146.36M | $85.71M | $16.29M | $1 | $- | $- | $- | $- | $- |
Other Current Assets | $31.33M | $61.23M | $73.01M | $97.11M | $14.54M | $21.11M | $26.17M | $6.37M | $2.51M | $2.04M |
Total Current Assets | $788.95M | $766.33M | $719.52M | $824.05M | $917.19M | $373.09M | $202.44M | $182.02M | $27.37M | $38.04M |
Property Plant Equipment Net | $19.04M | $21.09M | $24.89M | $26.08M | $24.52M | $15.77M | $977.92K | $- | $- | $- |
Goodwill | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Intangible Assets | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Goodwill and Intangible Assets | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Long Term Investments | $- | $3.24M | $- | $- | $- | $- | $- | $- | $- | $- |
Tax Assets | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Other Non-Current Assets | $77.06M | $-1.93M | $15.80M | $31.64M | $18.86M | $385.09K | $116.42K | $116.15K | $64.53K | $133.27K |
Total Non-Current Assets | $96.10M | $22.40M | $40.69M | $57.72M | $43.38M | $16.15M | $1.09M | $116.15K | $64.53K | $133.27K |
Other Assets | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Total Assets | $885.05M | $788.73M | $760.22M | $881.76M | $960.57M | $389.24M | $203.53M | $182.13M | $27.43M | $38.18M |
Account Payables | $38.57M | $37.52M | $37.34M | $16.91M | $8.48M | $8.36M | $10.25M | $3.66M | $2.55M | $2.48M |
Short Term Debt | $13.51M | $6.44M | $5.62M | $4.12M | $3.69M | $5.22M | $1.67M | $- | $- | $- |
Tax Payables | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Deferred Revenue | $- | $- | $- | $103.24M | $111.94M | $- | $- | $- | $- | $- |
Other Current Liabilities | $133.43M | $203.64M | $124.64M | $110.82M | $116.17M | $52.17M | $5.10M | $2.89M | $1.09M | $722.73K |
Total Current Liabilities | $185.51M | $247.59M | $167.61M | $131.85M | $128.33M | $65.75M | $17.02M | $6.55M | $3.64M | $3.20M |
Long Term Debt | $463.03M | $104.49M | $107.09M | $206.10M | $374.05M | $154.42M | $25.38M | $26.39M | $- | $- |
Deferred Revenue Non-Current | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Deferred Tax Liabilities Non-Current | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Other Non-Current Liabilities | $7.97M | $242.13M | $315.65M | $345.15M | $253.64M | $134.84M | $158.78K | $244.29K | $- | $- |
Total Non-Current Liabilities | $471.00M | $346.62M | $422.74M | $551.26M | $627.68M | $289.26M | $25.54M | $26.63M | $- | $- |
Other Liabilities | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Total Liabilities | $656.51M | $594.21M | $590.35M | $683.10M | $756.01M | $355.02M | $42.56M | $33.19M | $3.64M | $3.20M |
Preferred Stock | $- | $- | $- | $- | $- | $- | $- | $- | $92.05M | $77.19M |
Common Stock | $12.00K | $12.00K | $11.00K | $10.00K | $8.00K | $6.39K | $5.63K | $5.03K | $843 | $843 |
Retained Earnings | $-3.04B | $-2.84B | $-2.31B | $-1.66B | $-926.35M | $-581.47M | $-276.77M | $-149.26M | $-98.26M | $-71.13M |
Accumulated Other Comprehensive Income Loss | $-3.31M | $-3.54M | $-875.00K | $-2.09M | $-117.00K | $-153.78K | $-122.81K | $- | $- | $-0 |
Other Total Stockholders Equity | $3.27B | $3.04B | $2.48B | $1.86B | $1.13B | $615.85M | $437.86M | $298.20M | $30.00M | $28.92M |
Total Stockholders Equity | $228.54M | $194.52M | $169.87M | $198.66M | $204.56M | $34.23M | $160.97M | $148.94M | $23.79M | $34.98M |
Total Equity | $228.54M | $194.52M | $169.87M | $198.66M | $204.56M | $34.23M | $160.97M | $148.94M | $23.79M | $34.98M |
Total Liabilities and Stockholders Equity | $885.05M | $788.73M | $760.22M | $881.76M | $960.57M | $389.24M | $203.53M | $182.13M | $27.43M | $38.18M |
Minority Interest | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Total Liabilities and Total Equity | $885.05M | $788.73M | $760.22M | $881.76M | $960.57M | $389.24M | $203.53M | $182.13M | $27.43M | $38.18M |
Total Investments | $- | $4.35M | $6.50M | $60.36M | $311.87M | $- | $- | $- | $- | $- |
Total Debt | $469.78M | $110.93M | $112.71M | $210.22M | $377.73M | $157.03M | $27.04M | $26.39M | $- | $- |
Net Debt | $58.49M | $-240.26M | $-439.09M | $-429.97M | $-188.05M | $-194.95M | $-149.22M | $-149.25M | $-24.86M | $-36.00M |
Cash Flow Statement
Breakdown | December 31, 2024 | December 31, 2023 | December 31, 2022 | December 31, 2021 | December 31, 2020 | December 31, 2019 | December 31, 2018 | December 31, 2017 | December 31, 2016 | December 31, 2015 |
---|---|---|---|---|---|---|---|---|---|---|
Net Income | $-197.88M | $-528.63M | $-652.17M | $-746.35M | $-344.87M | $-304.71M | $-127.50M | $-51.01M | $-27.12M | $-46.52M |
Depreciation and Amortization | $1.80M | $1.70M | $1.49M | $1.49M | $637.00K | $239.68K | $- | $11.94K | $- | $- |
Deferred Income Tax | $- | $- | $- | $198.26M | $103.03M | $16.34M | $- | $153.69K | $- | $- |
Stock Based Compensation | $114.13M | $105.94M | $91.08M | $70.67M | $45.38M | $21.14M | $7.73M | $5.42M | $1.08M | $545.70K |
Change in Working Capital | $- | $-200.17M | $-15.70M | $-93.52M | $19.59M | $53.15M | $-12.04M | $-1.19M | $42.57K | $628.31K |
Accounts Receivables | $-58.48M | $- | $2.38M | $-10.10M | $- | $- | $- | $- | $- | $- |
Inventory | $-10.76M | $- | $-69.40M | $-16.32M | $- | $- | $- | $- | $- | $- |
Accounts Payables | $1.09M | $170.00K | $18.69M | $10.49M | $-54.00K | $-1.64M | $6.59M | $932.30K | $69.78K | $1.73M |
Other Working Capital | $- | $-200.34M | $32.63M | $-77.59M | $19.64M | $54.79M | $-18.63M | $-2.12M | $-27.21K | $-1.10M |
Other Non Cash Items | $-5.91M | $26.41M | $61.55M | $6.33M | $15.76M | $2.70M | $568.33K | $13.56K | $1.01M | $26.49M |
Net Cash Provided by Operating Activities | $-87.87M | $-594.74M | $-513.75M | $-563.13M | $-160.49M | $-211.14M | $-131.24M | $-46.60M | $-26.00M | $-18.86M |
Investments in Property Plant and Equipment | $-403.00K | $-773.00K | $-1.52M | $-1.10M | $-5.42M | $-1.69M | $- | $- | $- | $- |
Acquisitions Net | $- | $- | $-61.42M | $-248.72M | $311.57M | $- | $- | $- | $- | $- |
Purchases of Investments | $- | $- | $-331.86M | $-171.28M | $-879.07M | $- | $- | $- | $- | $- |
Sales Maturities of Investments | $- | $- | $393.28M | $420.00M | $567.50M | $- | $- | $- | $- | $- |
Other Investing Activities | $- | $99.00K | $61.42M | $248.72M | $-311.57M | $- | $- | $- | $- | $- |
Net Cash Used for Investing Activities | $-403.00K | $-674.00K | $59.89M | $247.62M | $-316.99M | $-1.69M | $- | $- | $- | $- |
Debt Repayment | $365.45M | $- | $- | $- | $322.87M | $184.21M | $- | $26.36M | $- | $- |
Common Stock Issued | $- | $384.39M | $380.12M | $380.36M | $381.42M | $109.58M | $131.19M | $150.06M | $14.86M | $1.72K |
Common Stock Repurchased | $4.51M | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Dividends Paid | $- | $- | $- | $- | $- | $- | $- | $- | $- | $- |
Other Financing Activities | $-216.21M | $10.11M | $-14.46M | $11.87M | $369.30M | $204.33M | $709.36K | $20.95M | $14.86M | $41.23M |
Net Cash Used Provided by Financing Activities | $149.24M | $394.50M | $365.66M | $392.24M | $692.18M | $388.54M | $131.90M | $197.38M | $14.86M | $41.24M |
Effect of Forex Changes on Cash | $-659.00K | $135.00K | $-488.00K | $-2.02M | $359.00K | $4.70K | $-38.43K | $- | $- | $- |
Net Change in Cash | $60.31M | $-200.78M | $-88.68M | $74.71M | $215.06M | $175.72M | $624.14K | $150.78M | $-11.14M | $22.38M |
Cash at End of Period | $412.61M | $352.30M | $553.07M | $641.75M | $567.04M | $351.99M | $176.27M | $175.64M | $24.86M | $36.00M |
Cash at Beginning of Period | $352.30M | $553.07M | $641.75M | $567.04M | $351.99M | $176.27M | $175.64M | $24.86M | $36.00M | $13.62M |
Operating Cash Flow | $-87.87M | $-594.74M | $-513.75M | $-563.13M | $-160.49M | $-211.14M | $-131.24M | $-46.60M | $-26.00M | $-18.86M |
Capital Expenditure | $-403.00K | $-773.00K | $-1.52M | $-1.10M | $-5.42M | $-1.69M | $- | $- | $- | $- |
Free Cash Flow | $-88.27M | $-595.51M | $-515.27M | $-564.23M | $-165.91M | $-212.83M | $-131.24M | $-46.60M | $-26.00M | $-18.86M |